Unique Wealth Strategies’s Catalyst Pharmaceutical CPRX Stock Holding History

Unique Wealth Strategies’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$649K	Buy	+20,656	New	+$610K	0.24%	122

Other funds holding CPRX

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

LTAS

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

RFG Advisory Birmingham, Alabama $6.4B AUM 19.93% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

EWM

Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return

OLA

Oliver Luxxe Assets Gladstone, New Jersey $680M AUM 47.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Unique Wealth Strategies's CPRX Position: Q2 2026 in Review

Unique Wealth Strategies opened a new position in Catalyst Pharmaceutical (CPRX) in Q2 2026: 20,656 shares worth $649K. The stake represents 0.24% of the portfolio and ranks #122 among its holdings.

36 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Unique Wealth Strategies held 20,656 shares of Catalyst Pharmaceutical worth $649K as of Q2 2026.
Catalyst Pharmaceutical was a new Unique Wealth Strategies position in Q2 2026.
Catalyst Pharmaceutical made up 0.24% of Unique Wealth Strategies's portfolio in Q2 2026, its #122 holding.
36 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Unique Wealth Strategies's 13F filing for Q2 2026, filed 15 Jul 2026.